Kymera Therapeutics
KYMR
#3536
Rank
โ‚น259.72 B
Marketcap
โ‚น4,010
Share price
1.32%
Change (1 day)
234.89%
Change (1 year)

Operating Margin for Kymera Therapeutics (KYMR)

Operating Margin as of November 2024 (TTM): -190.98%

According to Kymera Therapeutics's latest financial reports and stock price the company's current Operating Margin is -190.98%. At the end of 2023 the company had an Operating Margin of -186.99%.

Operating Margin history for Kymera Therapeutics from 2020 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-186.99%-43.44%
2022-330.60%140.26%
2021-137.60%2.72%
2020-133.96%-90.47%
2019-1,405.79%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
0.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.